Pharmaceuticals - Community Register


List of nationally authorised medicinal products for human use


Product name: Risperdal
Also marketed in the EU under the name(s): Actase, Belivon, Rehablit, Risperdaloro, Risperidone J-C, Rispolept, Rispolin
Active substance: Risperidone
Indication: RISPERDAL is indicated for the treatment of schizophrenia
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/10/2008 Referral EMEA/H/A-30/911 (2008)5939 of 07/10/2008
09/01/2009 Corrigendum (2008)5939 cor of 09/01/2009
26/02/2009 Corrigendum (2008)5939 cor of 26/02/2009